Related Experiment Video
Updated: Sep 3, 2025

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
Published on: January 17, 2025
[Post-COVID-19 severe cholangiopathy: report of 6 cases]
Marco Tulio Santisteban Arenas1, Laura Marcela Osorio Castrillón1, Luis Gonzalo Guevara Casallas1
1Universidad CES. Medellín, Colombia.
Insights
Severe COVID-19 can lead to a new liver condition called cholangiopathy. This novel entity presents with elevated alkaline phosphatase and bile duct abnormalities, potentially causing progressive biliary injury.
Area of Science:
- Hepatology
- Gastroenterology
- Infectious Diseases
Background:
- Coronavirus disease 2019 (COVID-19) primarily affects the respiratory system but can impact other organs.
- Liver chemistry abnormalities are common in COVID-19 patients, though typically transient.
- A subset of patients may develop more severe, persistent liver complications post-infection.
Purpose of the Study:
- To describe the clinical course and key findings of cholangiopathy following severe COVID-19.
- To characterize this novel post-COVID-19 liver complication.
- To highlight the potential for progressive biliary injury.
Main Methods:
- Retrospective case series of 6 patients diagnosed with cholangiopathy after severe COVID-19.
- Analysis of clinical data, liver chemistry tests (including alkaline phosphatase), and magnetic resonance imaging (MRI) findings.
- Assessment of the time course from COVID-19 diagnosis to cholangiopathy diagnosis.
Main Results:
- The study included 6 patients (4 men, 2 women) with a mean age of 56 years.
- The mean time from COVID-19 diagnosis to cholangiopathy diagnosis was 138 days.
- Key findings included elevated alkaline phosphatase and characteristic intrahepatic bile duct destructuring and beading on MRI.
Conclusions:
- Cholangiopathy following severe COVID-19 represents a novel clinical entity.
- This condition is associated with unique features and carries a risk of progressive biliary injury.
- Further research is needed to fully understand the pathophysiology and long-term outcomes of post-COVID-19 cholangiopathy, including its potential to lead to secondary biliary cirrhosis.
Abstract:
Coronavirus disease 2019 (COVID-19) is a predominantly respiratory tract infection with the capacity to affect other organs. Liver chemistry abnormalities are a frequent manifestation of COVID-19 but are usually transient. We describe the clinical course and most relevant findings of 6 patients who developed a cholangiopathy after severe COVID-19. The mean age of the patients, 4 men and 2 women, was 56 years and the mean time from COVID-19 diagnosis to diagnosis of cholangiopathy was 138 days. The features most important were the increase of alkaline phosphatase and destructuring and beading of the intrahepatic bile duct in magnetic resonance imaging. Cholangiopathy after severe COVID-19 constitutes a novel entity with unique features and potential for progressive biliary injury and secondary biliary cirrhosis. Further studies are required to understand this disease.
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Acute Pancreatitis II: Clinical Manifestations and Management
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
